Pregnenolone supplements are used to treat issues related to aging, stress, memory, and hormonal imbalance. Pregnenolone is a precursor to other important steroid hormones in the body like progesterone, estrogen, testosterone and cortisol.

Some Pregnenolone Supplements Market Size And Trends include improved mood, reduced stress and anxiety levels, enhanced memory function and neurogenesis. With rising geriatric population and growing health concerns, the demand for pregnenolone supplements is increasing globally.

The Global pregnenolone supplements market is estimated to be valued at US$ 606.75 Mn in 2024 and is expected to exhibit a CAGR of 5.6% over the forecast period 2024 To 2031.

Key Takeaways

Key players operating in the pregnenolone supplements are Thermo Fisher Scientific Inc., Agilent Technologies, Inc, bioMérieux SA, F. Hoffmann-La Roche Ltd , QIAGEN, Illumina, Inc., Oxford Nanopore Technologies plc., BGI, PerkinElmer Genomics, and Pierian.

The Pregnenolone Supplements Market Demand include increasing adoption of direct-to-consumer genetic testing. Direct-to-consumer genetic testing is opening new revenue streams for manufactures. Additionally, growing awareness about benefits of dietary supplements is fueling the demand.

Technological advancements like next-generation sequencing techniques are enabling enhanced precision and throughput. NGS allows analysis of entire human genomes more rapidly and accurately. This is translating to better clinical diagnosis and management of health conditions.

Get More Insights On, Pregnentolone Supplements Market